sickle-cell anemia

Editors at the journal Nature Medicine recently asked researchers and public health experts from around the world to identify clinical trials that will shape medicine in 2023.  They came up with a varied list of candidates, from cervical and prostate cancer screening protocols to gene therapy for muscular dystrophy and new drugs for Parkinson’s disease and Alzheimer’s disease.  The selections are arbitrary and idiosyncratic, but they are interesting, nevertheless. 
A small study conducted by the National Institutes of Health shows bone marrow transplantation as an effective means to treat severe sickle cell
A drug that had previously been proven effective for treatment of adults and children with sickle- cell anemia has been found to significantly cut annual hospital costs for children with the disease